The development of in silico methods that support human health and environmental risk assessment of engineered nanomaterials is nowadays of high interest, because the application of those methods enables to fill the existing experimental data gaps.
No takes yet. Share an insight, caveat, or question.
Gajewicz et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: